The eISF, or electronic Investigator Site File, is the digital version of the paper-based investigator site file (ISF). It enables the collection in digital form of essential documents that demonstrate a clinical trial was conducted in accordance with Good Clinical Practice (GCP) guidelines, as well as regulatory and sponsor requirements. These documents include the protocol, informed consent forms, study reports, lab results, and other documentation related to the trial.
Leads to this page The use of eISFs has several advantages over paper-based ISFs :
• efficiency in document management
• increases accuracy and completeness of data
• enhances security of sensitive information
• facilitates remote monitoring of study sites
• real-time data access and sharing between sites, sponsors, and regulatory agencies
Theuse of eISFs represents a significant step forward in the conduct of clinical research, enabling faster and more efficient trial management while ensuring compliance with regulatory and ethical standards.
December 19, 2024
2-4 February 2025 – Copenhagen | Booth 21 We’re thrilled to showcase CleanWeb™, our advanced eClinical Suite for managing Clinical Trials, Registries, and Managed Access Programs. With 20+ integrated modules, CleanWeb™ simplifies research and drives innovation. Meet our team and discover how we can support your upcoming clinical projects. Alongside our CRO Alliance partners (CERC, […]
December 19, 2024
Trial Site News The United Kingdom (UK) government has announced a £100 million public-private investment to establish 20 research/trial site hubs across the country, a move aimed at bolstering clinical trials and advancing treatment access. This initiative, part of the Voluntary Scheme for Branded Medicine Pricing, Access and Growth (VPAG) Investment Programme, is a collaboration between the […]
December 19, 2024
Med City News LLMs bring great potential to help the healthcare industry center care around patients’ needs by improving communication, access, and engagement. However, LLMs also present significant challenges associated with privacy and bias that also must be considered. Large language models (LLMs) have generated buzz in the medical industry for their ability to pass […]